Articles from Quoin Pharmaceuticals, Inc.

REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

Available Clinical Data from Six Subjects Demonstrates Well Defined Efficacy Signals Across a Number of Study Endpoints

By Quoin Pharmaceuticals, Inc. · Via GlobeNewswire · October 24, 2023